347
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Revaprazan-loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluation

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 788-793 | Received 31 Jul 2018, Accepted 16 Mar 2019, Published online: 24 Apr 2019

References

  • Chaudhari SP, Dugar RP. 2017. Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Deliv Sci Tec. 41:68–77.
  • Choi HY, Noh YH, Jin SJ, Kim YH, Kim MJ, Sung H, Jang SB, Lee SJ, Bae KS, Lim HS. 2012. Bioavailability and tolerability of combination treatment with revaprazan 200 mg + itopride 150 mg: a randomised crossover study in healthy male Korean volunteers. Clin Ther. 34:1999–2010.
  • Cho JH, Kim YI, Kim DW, Yousaf AM, Kim JO, Woo JS, Yong CS, Choi HG. 2014. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. Eur J Pharm Sci. 54:1–7.
  • Inatomi N, Matsukawa J, Sakurai Y, Otake K. 2016. Potassium-competitive acid blockers: advanced therapeutic option for acid-related diseases. Pharmacol Ther. 168:12–22.
  • Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi H-G. 2010. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm. 395:161–166.
  • Kim DS, Choi JS, Kim DW, Kim KS, Seo YG, Cho KH, Kim JO, Yong CS, Youn YS, Lim SJ, et al. 2016. Comparison of solvent-wetted and kneaded l-sulpiride-loaded solid dispersions: powder characterization and in vivo evaluation. Int J Pharm. 511:351–358.
  • Kim DS, Kim DW, Kim KS, Choi JS, Seo YG, Youn YS, Oh KT, Yong CS, Kim JO, Jin SG, et al. 2016. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability. Colloids Surf B Biointerfaces. 147:250–257.
  • Kim DW, Kwon MS, Yousaf AM, Balakrishnan P, Park JH, Kim DS, Lee BJ, Park YJ, Yong CS, Kim JO, et al. 2014. Comparison of a solid SMEDDS and solid dispersion for enhanced stability and oral absorption of clopidogrel napadisilate. Carbohydr Polym. 114:365–374.
  • Kim JC, Kim KS, Kim DS, Jin SG, Kim DW, Kim YI, Park JH, Kim JO, Yong CS, Youn YS, et al. 2016C. Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor. Int J Pharm. 506:93–101.
  • Kim KS, Jin SG, Mustapha O, Yousaf AM, Kim DW, Kim YH, Kim JO, Yong CS, Woo JS, Choi HG. 2015. Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs. Int J Pharm. 490:273–280.
  • Kim KS, Kim JC, Jin SG, Kim DW, Kim DS, Yong CS, Kim JO, Youn YS, Oh KT, Woo JS, et al. 2016D. Development of novel prasugrel base microsphere-loaded tablet with enhanced stability: physicochemical characterization and in vivo evaluation in beagle dogs. Colloids Surf B Biointerfaces. 146:754–761.
  • Lee JS, Cho JY, Song H, Kim EH, Hahm KB. 2012. Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling. J Clin Biochem Nutr. 51:77–83.
  • Lee SN, Poudel BK, Tran TH, Marasini N, Pradhan R, Lee YI, Lee DW, Woo JS, Choi H-G, Yong CS, Kim JO. 2013. A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution. Arch Pharm Res. 36:79–85.
  • Li DX, Yan YD, Oh DH, Yang KY, Seo YG, Kim JO, Kim YI, Yong CS, Choi HG. 2010. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer. Drug Deliv. 17:322–329.
  • Li W, Quan P, Zhang Y, Cheng J, Liu J, Cun D, Xiang R, Fang L. 2014. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions. Int J Pharm. 460:13–23.
  • Marasini N, Tran TH, Poudel BK, Cho HJ, Choi YK, Chi SC, Choi HG, Yong CS, Kim JO. 2013. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Int J Pharm. 441:424–432.
  • Mustapha O, Din FU, Kim DW, Park JH, Woo KB, Lim S-J, Youn YS, Cho KH, Rashid R, Yousaf AM, et al. 2016. Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation. J Microencapsul. 33:323–330.
  • Park JH, Kim DS, Mustapha O, Yousaf AM, Kim JS, Kim DW, Yong CS, Youn YS, Oh KT, Lim SJ, et al. 2018. Comparison of a revaprazan-loaded solid dispersion, solid SNEDDS and inclusion compound: physicochemical characterisation and pharmacokinetics. Colloids Surf B Biointerfaces. 162:420–426.
  • Rashid R, Kim DW, Din FU, Mustapha O, Yousaf AM, Park JH, Kim JO, Yong CS, Choi HG. 2015B. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and oral absorption of ezetimibe-loaded solid dispersion. Carbohydr Polym. 130:26–31.
  • Rashid R, Kim DW, Yousaf AM, Mustapha O, Din FU, Park JH, Yong CS, Oh YK, Youn YS, Kim JO, et al. 2015. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J Nanomedicine. 10:6147–6159.
  • Vasconcelos T, Sarmento B, Costa P. 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 12:1068–1075.
  • Yang KY, Hwang DH, Yousaf AM, Kim DW, Shin YJ, Bas ON, Kim YI, Kim JO, Yong CS, Choi HG. 2013. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: Physicochemical characterization and in vivo evaluation. Int J Nanomedicine. 8:3333–3343.
  • Yousaf AM, Kim DW, Kim JK, Kim JO, Yong CS, Choi H-G. 2015. Novel fenofibrate-loaded gelatin microcapsules with enhanced solubility and excellent flowability: preparation and physicochemical characterization. Powder Technol. 275:257–262.
  • Yousaf AM, Kim DW, Kim DS, Kim JO, Youn YS, Cho KH, Yong CS, Choi HG. 2016. Influence of polyvinylpyrrolidone quantity on the solubility, crystallinity and oral bioavailability of fenofibrate in solvent-evaporated microspheres. J Microencapsul. 33:365–371.
  • Yousaf AM, Kim DW, Kim JO, Chang PS, Baek HH, Lim SJ, Cho KH, Yong CS, Choi HG. 2015. Characterization of physicochemical properties of spray-dried solid dispersions loaded with unmodified crystalline fenofibrate. CPA. 11:139–144.
  • Yousaf AM, Kim DW, Oh YK, Yong CS, Kim JO, Choi HG. 2015. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Int J Nanomedicine. 10:1819–1830.
  • Yousaf AM, Mustapha O, Kim DW, Kim DS, Kim KS, Jin SG, Yong CS, Youn YS, Oh YK, Kim JO, et al. 2016. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Int J Nanomedicine. 11:213–221.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.